Back to results
US 2026/0284119 A1Published application
Method of prolonging the lifespan of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (cadasil) using a cerebrolysin® preparation
AssigneeEver Neuro Pharma Bmbh
InventorsStefan WINTER, Herbert Mössler
Life of this patent
Estimating the term…
Abstract
Disclosed is cerebrolysin for use in reducing mortality in CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) patients.
Claims19
1-12. (Canceled)
A method of treating a patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) comprising:
- obtaining cerebrolysin;
- and
- administering the cerebrolysin to the patient;
- wherein CADASIL is treated in the patient.
1 more element
Dependencies are inferred from the claim text.